Please use this identifier to cite or link to this item: https://hdl.handle.net/11147/7597
Full metadata record
DC FieldValueLanguage
dc.contributor.authorÖzçınar, Özge-
dc.contributor.authorTağ, Özgür-
dc.contributor.authorYusufoğlu, Hasan-
dc.contributor.authorKıvçak, Bijen-
dc.contributor.authorBedir, Erdal-
dc.date.accessioned2020-01-17T07:53:32Z-
dc.date.available2020-01-17T07:53:32Z-
dc.date.issued2018-06en_US
dc.identifier.citationÖzçınar, Ö., Tağ, Ö., Yusufoğlu, H., Kıvçak, B., and Bedir, E. (2018). Biotransformation of neoruscogenin by the endophytic fungus Alternaria eureka. Journal of Natural Products, 81(6), 1357-1367. doi:10.1021/acs.jnatprod.7b00898en_US
dc.identifier.issn0163-3864-
dc.identifier.issn0163-3864-
dc.identifier.issn1520-6025-
dc.identifier.urihttps://doi.org/10.1021/acs.jnatprod.7b00898-
dc.identifier.urihttps://hdl.handle.net/11147/7597-
dc.description.abstractBiotransformation of neoruscogenin (NR, 1, spirosta-5,25(27)-diene-1β,3β-diol), the major bioactive sapogenin of Ruscus preparations, was carried out with the endophytic fungus Alternaria eureka. Fourteen new biotransformation products (2-15) were isolated, and their structures were elucidated by NMR and HRESIMS data analyses. A. eureka affected mainly oxygenation, oxidation, and epoxidation reactions on the B and C rings of the sapogenin to afford compounds 8-15. In addition to these, cleavage of the spiroketal system as in compounds 2-7 and subsequent transformations provided unusual metabolites. This is the first study reporting conversion of the spirostanol skeleton to cholestane-type metabolites 2-5. Additionally, the cleavage of the C-22/C-26 oxygen bridge yielding a furostanol-type steroidal framework and subsequent formation of the epoxy bridge between C-18 and C-22 in 7 was encountered for the first time in steroid chemistry.en_US
dc.description.sponsorshipEge University (15ECZ9011); TUBITAK (114Z958)en_US
dc.language.isoenen_US
dc.publisherAmerican Chemical Societyen_US
dc.relation.ispartofJournal of Natural Productsen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectNeoruscogeninen_US
dc.subjectBiotransformationen_US
dc.subjectAlternaria eurekaen_US
dc.subjectDrug synthesisen_US
dc.subjectSapogeninsen_US
dc.titleBiotransformation of neoruscogenin by the endophytic fungus Alternaria eurekaen_US
dc.typeArticleen_US
dc.authorid0000-0003-1262-063Xen_US
dc.institutionauthorBedir, Erdal-
dc.departmentİzmir Institute of Technology. Bioengineeringen_US
dc.identifier.volume81en_US
dc.identifier.issue6en_US
dc.identifier.startpage1357en_US
dc.identifier.endpage1367en_US
dc.identifier.wosWOS:000436527100006en_US
dc.identifier.scopus2-s2.0-85049097127en_US
dc.relation.tubitakinfo:eu-repo/grantAgreement/TUBITAK/KBAG/114Z958-
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.doi10.1021/acs.jnatprod.7b00898-
dc.identifier.pmid29893560en_US
dc.relation.doi10.1021/acs.jnatprod.7b00898en_US
dc.coverage.doi10.1021/acs.jnatprod.7b00898en_US
dc.identifier.wosqualityQ1-
dc.identifier.scopusqualityQ1-
item.fulltextWith Fulltext-
item.openairetypeArticle-
item.cerifentitytypePublications-
item.grantfulltextopen-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.dept03.01. Department of Bioengineering-
Appears in Collections:Bioengineering / Biyomühendislik
PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection
Files in This Item:
File Description SizeFormat 
acs.jnatprod.7b00898.pdfMakale (Article)839 kBAdobe PDFThumbnail
View/Open
Show simple item record



CORE Recommender

SCOPUSTM   
Citations

16
checked on Apr 5, 2024

WEB OF SCIENCETM
Citations

13
checked on Mar 23, 2024

Page view(s)

596
checked on Apr 15, 2024

Download(s)

320
checked on Apr 15, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.